The UK Competition Authority investigates a pharmaceutical company for abuse of dominance (Essential Pharma)

KEYWORDS
Reference

UK Competition Authority, Essential Pharma, Press Release, 6 October 2020

On 6 October 2020, the Competition and Markets Authority ( CMA ) started an inquiry into Essential Pharma to determine whether that company abused an allegedly dominant position when announcing the withdrawal from the UK market of Priadel®, a

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.